Elisabeth Rosenthal KFF Health News Health care has proved a vulnerable target for the firehose of cuts and policy changes President Donald Trump ordered in the name of reducing waste and improving ...

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...

While charitable dollars have flowed in to plug some gaps, “philanthropy cannot replace federal funding,” said Dustin Sposato ...

Healthcare has proved a vulnerable target for the firehose of cuts and policy changes President Donald Trump ordered in the ...

In the medium- to long-term, we expect Seek’s core strategic focus to revolve around protecting its ANZ business from competitive pressure, especially from Microsoft-owned LinkedIn. LinkedIn has ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

Crop protection constitutes the lion's 60% share of our fair value estimate, with the 40% balance from seeds. Our fair value breakdown includes 15% for APAC, 27% for Europe, 17% for North America, and ...

While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

"It's all in your head." For countless patients seeking answers to unexplained symptoms, this dismissive phrase from healthcare professionals triggers a cascade of harmful consequences.

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.